IND submission is a critical milestone in mAb development — but analytical methods established at this stage must ultimately support validation, tech transfer, and evolving regulatory expectations. Among these, residual...
We are very excited to invite you to our BVS, in collaboration with JLL Biotech Community Innovation Night at 115 Munson! Mark your calendars for a great opportunity to connect...
The DIA Global Annual Meeting is where life sciences professionals from industry, regulatory agencies, patients, and academia come together to drive breakthroughs in healthcare — advancing science, policy, and patient...
Explore how advanced nanoparticle engineering is transforming formulation across both small and large molecule modalities. Dr. Chris Worrall highlights how Nanoform’s technologies enable higher drug‑loading oral tablets, ultra‑high‑concentration biologic formulations...
In this session, leading cell therapy CDMOs will break down how they support programs across development—from early process work through GMP manufacturing, scale-up, and commercial readiness—and where different approaches can...
Increasing titers isn’t the only way to maximize process efficiency. Whether you’re optimizing an existing process or developing the next generation of biologics, we can help you identify the levers...
In this session, leading CDMO experts will break down the key decisions across host cell selection, vector design, and clone screening strategies, and explain how those choices impact expression, scalability,...
What You’ll Learn: Gain insights into how renewed leasing activity, selective capital and improving absorption are reshaping demand, investment, and development decisions across the Bay Area life sciences market. Learn...
Clinical trials sit at a unique intersection of science, patients, and clinical care, and for decades, the “gold standard” has prioritized the rigor of the data, often at the expense...
Join us for this digital event designed for pharmaceutical and biopharmaceutical companies seeking reliable CDMO partnerships to accelerate their microbial programs from development through commercial manufacturing. By attending this digital...
